caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932461548

Michael ReyM.D.

Pulmonary DiseasePhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
856
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
30
Brand share
43.6%
Top prescribed drugs
Azithromycin74 claims
Elexacaftor/Tezacaftor/Ivacaft71 claims
Montelukast Sodium70 claims
Prednisone59 claims
Fluticasone Propionate56 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
327
Unique beneficiaries
—
Total services
481
Distinct HCPCS
6
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 571 Pulmonary Disease providers in PA — below median (cohort median 707).